PRP Procedure – Swiss Plasmabiotech GmbH

SPB PRP Procedure

The Plasmabiotech Method

The Plasmabiotech Method is a universal regenerative approach that works in harmony with the body’s natural healing mechanisms. It follows the same fundamental biological processes of regeneration, with variations only in the duration of treatment depending on the characteristics of the specific tissue.

Thanks to this mechanism, the method can be applied in a wide range of medical fields, including aesthetic medicine, stomatology, trichology, orthopedics and traumatology, sports medicine, urology, and gynecology.

Across these indications, the Plasmabiotech method helps activate the body’s own regenerative potential. By stimulating the natural biological reserves of the human body, the treatment supports tissue repair and recovery, helping patients restore health, vitality, and overall well-being.

The Stages of the Plasmabiotech Procedure

The essence of the Plasmabiotech method lies in injecting plasma with a high concentration of platelets into the human body, which stimulates cellular regeneration processes.

The Plasmabiotech procedure typically takes no longer than 30 minutes and consists of the following steps:

Blood Collection:

Blood is drawn from a vein into a special vacuum tube. After preparing the patient, venipuncture is performed using a sterile needle, and between 10 and 60 ml of blood (depending on the treatment protocol) is collected.

The collection of such a small volume of blood does not negatively affect the patient’s health and does not interfere with the normal functioning of the body.

Centrifugation and Plasma Separation:
Autologous platelet-rich plasma (PRP) is separated from whole blood through centrifugation. To obtain plasma with high therapeutic potential, the blood must be properly processed. Normally, the platelet concentration in human blood ranges between 150,000 and 350,000 platelets per microliter. For an effective regenerative stimulation, this concentration should be increased to approximately 1,000,000 platelets per microliter.

Plasma with such a high platelet concentration can be obtained by centrifuging the blood in specialized biotechnological Plasmabiotech tubes. The efficiency and safety of the procedure are optimized when certified Plasmabiotech equipment is used.

During centrifugation, the tubes are placed symmetrically in the centrifuge rotor (in opposite positions) to ensure proper balance and optimal plasma separation.

Plasma Injection:
The plasma is injected into the treatment area. Plasmabiotech-certified tubes enable the efficient separation of blood into three fractions: red blood cells, plasma suspension, and the platelet-rich fraction (autologous plasma rich in growth factors).

During this process, the separated autologous platelet-rich plasma is collected and injected into the targeted treatment areas. Autologous plasma acts as a powerful biological stimulator of tissue regeneration and contains a high concentration of growth factors, proteins, hormones, and vitamins in their natural proportions.

Because platelet-rich plasma is derived from the patient’s own blood, it ensures complete biocompatibility with the body and eliminates the risk of immunological reactions, allergic responses, or tissue rejection.